摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-[(E)-3-phenylprop-2-enoyl]phenyl]pyrrole-2,5-dione | 949923-50-6

中文名称
——
中文别名
——
英文名称
1-[4-[(E)-3-phenylprop-2-enoyl]phenyl]pyrrole-2,5-dione
英文别名
——
1-[4-[(E)-3-phenylprop-2-enoyl]phenyl]pyrrole-2,5-dione化学式
CAS
949923-50-6
化学式
C19H13NO3
mdl
——
分子量
303.317
InChiKey
ZJTXBNPJEYRAAZ-IZZDOVSWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    54.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-[4-[(E)-3-phenylprop-2-enoyl]phenyl]pyrrole-2,5-dione苄硫醇 在 3-(N-morpholino)propanesulfonic acid buffer 作用下, 以 二甲基亚砜 为溶剂, 反应 72.0h, 以50%的产率得到1-(4-(3-(benzylthio)-3-phenylpropanoyl)phenyl)-3-(benzylthio)pyrrolidine-2,5-dione
    参考文献:
    名称:
    Cytostatic activity of novel 4′-aminochalcone-based imides
    摘要:
    A series of nine 1-(4-((E)-3-arylacryloyl)phenyl)-1H-pyrrole-2,5-diones 3a-i (4 '-aminochalcone-based maleimides)was synthesized as candidate cytotoxic agents. The efficacy of these potential cytotoxics were evaluated against three representative cell lines and more than half of the drug candidates proved to exhibit significant cytostatic activity in vitro. QSAR studies using statistical analyses on several physicochemical parameters and IC(50) values resulted in a few very important correlations which will aid in later the amplification of the project. Representative test compounds were well tolerated by mice in in vivo survival and toxicity studies. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.05.094
  • 作为产物:
    参考文献:
    名称:
    Cytostatic activity of novel 4′-aminochalcone-based imides
    摘要:
    A series of nine 1-(4-((E)-3-arylacryloyl)phenyl)-1H-pyrrole-2,5-diones 3a-i (4 '-aminochalcone-based maleimides)was synthesized as candidate cytotoxic agents. The efficacy of these potential cytotoxics were evaluated against three representative cell lines and more than half of the drug candidates proved to exhibit significant cytostatic activity in vitro. QSAR studies using statistical analyses on several physicochemical parameters and IC(50) values resulted in a few very important correlations which will aid in later the amplification of the project. Representative test compounds were well tolerated by mice in in vivo survival and toxicity studies. (c) 2007 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.05.094
点击查看最新优质反应信息

文献信息

  • [EN] (E)-1-(4-CINNAMOYL-PHENYL)-1 H-PYRROLE-2,5-DIONE DERIVATIVES HAVING ANTI-CANCEROGENIC EFFICIENCY<br/>[FR] DÉRIVÉS DE (E)-1-(4-CINNAMOYL-PHÉNYL)-1H-PYRROLE-2,5-DIONE AYANT UN EFFET ANTI-CANCÉREUX
    申请人:BUDAK YAKUP
    公开号:WO2018226178A2
    公开(公告)日:2018-12-13
    The present invention relates to (E)-1 -(4-cinnamoyl-phenyl)-1 H-pyrrole-2,5-dione derivatives shown by Formula (1), the preparation methods of these molecules, the formulations comprising these molecules and the usage of these molecules in treatment of cancer.
  • Cytostatic activity of novel 4′-aminochalcone-based imides
    作者:Amitabh Jha、Chandrani Mukherjee、Alfred J. Rolle、Erik De Clercq、Jan Balzarini、James P. Stables
    DOI:10.1016/j.bmcl.2007.05.094
    日期:2007.8
    A series of nine 1-(4-((E)-3-arylacryloyl)phenyl)-1H-pyrrole-2,5-diones 3a-i (4 '-aminochalcone-based maleimides)was synthesized as candidate cytotoxic agents. The efficacy of these potential cytotoxics were evaluated against three representative cell lines and more than half of the drug candidates proved to exhibit significant cytostatic activity in vitro. QSAR studies using statistical analyses on several physicochemical parameters and IC(50) values resulted in a few very important correlations which will aid in later the amplification of the project. Representative test compounds were well tolerated by mice in in vivo survival and toxicity studies. (c) 2007 Elsevier Ltd. All rights reserved.
查看更多